Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...) as an additional HIV prevention choice, as part of combination HIV prevention approaches. LEN, administered twice a year as PrEP, has been shown to be highly effective at reducing the risk of HIV acquisition. In this guideline, WHO also recommends using HIV rapid diagnostic tests (RDTs) for individuals initiating or continuing long-acting injectable PrEP, such as LEN and long acting injectable cabotegravir (CAB-LA). Flexible HIV testing approaches are essential for ensuring that testing does not become a barrier to accessing or continuing PrEP, including long-acting injectable options.
more
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
The ILO has joined forces with Gallup to carry out a groundbreaking global survey covering 50 countries that sheds further light on the causes of the persistence of HIV-related stigma and discrimination in the world of work.
L'OIT a uni ses forces à celles de Gallup pour mener une enquête mondiale inédite couvrant 50 pays et permettant de mieux comprendre les causes de la stigmatisation et de la discrimination persistantes liées au VIH dans le monde du travail.
La OIT ha unido fuerzas con Gallup para llevar a cabo una innovadora encuesta mundial que abarca 50 países y que arroja más luz sobre las causas de la persistencia del estigma y la discriminación relacionados con el VIH en el mundo del trabajo.
В этих новых руководящих принципах рекомендуется использовать упрощенный алгоритм скрининга, основанного на четырех клинических симптомах, для выявления ...иц, которым показана либо ПТИ, либо дальнейшая диагностика для выявления ТБ и других заболеваний.
more
The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD)